AQR Arbitrage’s Eli Lilly LLY Stock Holding History

AQR Arbitrage’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,557	Closed	-$260K	–	1209
2020 Q4	$260K	Buy	+1,557	New	+$232K	0.01%	883

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AQR Arbitrage's LLY Position: Q1 2021 in Review

AQR Arbitrage sold out of Eli Lilly (LLY) in Q1 2021, closing a stake of 1,557 shares — an estimated $260K sold.

AQR Arbitrage first reported a position in LLY in Q4 2020 and held it in 1 quarter. The position peaked at $260K in Q4 2020. 1,949 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

AQR Arbitrage reported no remaining Eli Lilly position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 1,557 Eli Lilly shares in Q1 2021, an estimated $260K.
AQR Arbitrage first reported a position in Eli Lilly in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Eli Lilly position peaked at $260K in Q4 2020.
1,949 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.